166 related articles for article (PubMed ID: 31028254)
1. A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates.
Douglas AD; Baldeviano GC; Jin J; Miura K; Diouf A; Zenonos ZA; Ventocilla JA; Silk SE; Marshall JM; Alanine DGW; Wang C; Edwards NJ; Leiva KP; Gomez-Puerta LA; Lucas CM; Wright GJ; Long CA; Royal JM; Draper SJ
Nat Commun; 2019 Apr; 10(1):1953. PubMed ID: 31028254
[TBL] [Abstract][Full Text] [Related]
2. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
Front Immunol; 2021; 12():720550. PubMed ID: 34733274
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
4. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Douglas AD; Williams AR; Illingworth JJ; Kamuyu G; Biswas S; Goodman AL; Wyllie DH; Crosnier C; Miura K; Wright GJ; Long CA; Osier FH; Marsh K; Turner AV; Hill AV; Draper SJ
Nat Commun; 2011 Dec; 2():601. PubMed ID: 22186897
[TBL] [Abstract][Full Text] [Related]
5. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
[TBL] [Abstract][Full Text] [Related]
6. Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen.
Knudsen AS; Walker MR; Agullet JP; Björnsson KH; Bassi MR; Barfod L
Sci Rep; 2022 Feb; 12(1):3040. PubMed ID: 35197516
[TBL] [Abstract][Full Text] [Related]
7. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
Alanine DGW; Quinkert D; Kumarasingha R; Mehmood S; Donnellan FR; Minkah NK; Dadonaite B; Diouf A; Galaway F; Silk SE; Jamwal A; Marshall JM; Miura K; Foquet L; Elias SC; Labbé GM; Douglas AD; Jin J; Payne RO; Illingworth JJ; Pattinson DJ; Pulido D; Williams BG; de Jongh WA; Wright GJ; Kappe SHI; Robinson CV; Long CA; Crabb BS; Gilson PR; Higgins MK; Draper SJ
Cell; 2019 Jun; 178(1):216-228.e21. PubMed ID: 31204103
[TBL] [Abstract][Full Text] [Related]
8. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
[TBL] [Abstract][Full Text] [Related]
9. A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.
Douglas AD; Baldeviano GC; Lucas CM; Lugo-Roman LA; Crosnier C; Bartholdson SJ; Diouf A; Miura K; Lambert LE; Ventocilla JA; Leiva KP; Milne KH; Illingworth JJ; Spencer AJ; Hjerrild KA; Alanine DG; Turner AV; Moorhead JT; Edgel KA; Wu Y; Long CA; Wright GJ; Lescano AG; Draper SJ
Cell Host Microbe; 2015 Jan; 17(1):130-9. PubMed ID: 25590760
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
Douglas AD; Williams AR; Knuepfer E; Illingworth JJ; Furze JM; Crosnier C; Choudhary P; Bustamante LY; Zakutansky SE; Awuah DK; Alanine DG; Theron M; Worth A; Shimkets R; Rayner JC; Holder AA; Wright GJ; Draper SJ
J Immunol; 2014 Jan; 192(1):245-58. PubMed ID: 24293631
[TBL] [Abstract][Full Text] [Related]
11. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
[TBL] [Abstract][Full Text] [Related]
12. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
13. Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys.
De SL; Stanisic DI; van Breda K; Bellete B; Harris I; McCallum F; Edstein MD; Good MF
Int J Parasitol; 2016 Aug; 46(9):581-91. PubMed ID: 27238088
[TBL] [Abstract][Full Text] [Related]
14. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
[TBL] [Abstract][Full Text] [Related]
15. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
[TBL] [Abstract][Full Text] [Related]
16. Functional Comparison of Blood-Stage
Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
Front Immunol; 2019; 10():1254. PubMed ID: 31214195
[TBL] [Abstract][Full Text] [Related]
17. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
18. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
[TBL] [Abstract][Full Text] [Related]
20. Immunization of Aotus monkeys with recombinant Plasmodium falciparum hybrid proteins does not reproducibly result in protection from malaria infection.
Kocken CH; Hundt E; Knapp B; Brazel D; Enders B; Narum DL; Wubben JA; Thomas AW
Infect Immun; 1998 Jan; 66(1):373-5. PubMed ID: 9423884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
